NYLI U.S. Large Cap R&D Leaders ETF (LRND)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NYLI U.S. Large Cap R&D Leaders ETF (LRND) with AI Score 44/100 (Weak). NYLI U. S. Large Cap R&D Leaders ETF (LRND) aims to replicate the performance of the NYLI U. Market cap: 0, Sector: Financial services.
Last analyzed: Mar 16, 2026NYLI U.S. Large Cap R&D Leaders ETF (LRND) Financial Services Profile
NYLI U.S. Large Cap R&D Leaders ETF (LRND) offers exposure to U.S. large-cap companies demonstrating robust R&D investment. The fund tracks the NYLI U.S. Large Cap R&D Leaders Index, providing investors with a focused approach to capturing innovation-driven growth within the large-cap equity space, while carrying a beta of 1.09.
Investment Thesis
NYLI U.S. Large Cap R&D Leaders ETF (LRND) presents an investment opportunity for those seeking exposure to innovative U.S. large-cap companies. The fund's focus on R&D leaders aims to capture growth potential driven by technological advancements. A key value driver is the consistent and effective use of R&D investment by the companies within the index. Upcoming catalysts include potential breakthroughs or advancements from the R&D efforts of the underlying companies. However, potential risks include the uncertainty of R&D outcomes and the possibility of underperformance compared to broader market indices. With a market cap of $0.01 billion and a beta of 1.09, LRND offers a targeted approach to investing in innovation. The absence of a dividend yield may deter income-focused investors.
Based on FMP financials and quantitative analysis
Key Highlights
- The ETF tracks the NYLI U.S. Large Cap R&D Leaders Index, providing exposure to companies prioritizing R&D investment.
- The fund focuses on U.S. large-cap equity securities, offering a targeted approach to innovation-driven growth.
- The ETF operates with the objective of replicating the price and yield performance of its underlying index before fees and expenses.
- The fund's investment strategy involves holding a portfolio of stocks that meet the index's criteria for R&D leadership.
- The ETF has a market capitalization of $0.01 billion, indicating its size within the asset management landscape.
Competitors & Peers
Strengths
- Focus on R&D leaders.
- Tracks a specific index.
- Provides targeted exposure to innovation.
- Cost-effective investment option.
Weaknesses
- Small market capitalization.
- No dividend yield.
- Dependence on the performance of the underlying index.
- Potential for underperformance compared to broader market indices.
Catalysts
- Ongoing: Potential breakthroughs or advancements from the R&D efforts of the underlying companies.
- Upcoming: Expansion of the NYLI U.S. Large Cap R&D Leaders Index.
- Ongoing: Increased investor interest in innovation and technology.
Risks
- Potential: Uncertainty of R&D outcomes.
- Ongoing: Competition from other ETFs.
- Potential: Economic downturn impacting R&D spending.
- Potential: Changes in the regulatory environment.
Growth Opportunities
- Growth Opportunity 1: Increased investor interest in innovation and technology could drive demand for LRND. As investors seek exposure to companies at the forefront of technological advancements, LRND's focus on R&D leaders positions it to benefit from this trend. The market for innovation-focused ETFs is growing, and LRND's targeted approach may attract investors looking for specific exposure to R&D-driven companies. This growth opportunity is ongoing and depends on the continued emphasis on innovation in the market.
- Growth Opportunity 2: Expansion of the NYLI U.S. Large Cap R&D Leaders Index could lead to increased diversification and improved performance for LRND. As the index evolves to include more companies or refine its selection criteria, LRND's portfolio could benefit from greater diversification and exposure to emerging R&D leaders. This growth opportunity is upcoming and depends on the index provider's decisions regarding index composition and methodology.
- Growth Opportunity 3: Strategic partnerships with financial advisors and institutions could increase LRND's distribution and reach. By collaborating with key players in the financial industry, LRND can expand its investor base and attract more assets under management. This growth opportunity is ongoing and requires proactive efforts to establish and maintain relationships with financial professionals.
- Growth Opportunity 4: Development of new marketing campaigns highlighting LRND's unique investment strategy could raise awareness and attract new investors. By effectively communicating the fund's focus on R&D leaders and its potential for innovation-driven growth, LRND can differentiate itself from competitors and attract investors seeking targeted exposure to this segment of the market. This growth opportunity is ongoing and requires creative and effective marketing strategies.
- Growth Opportunity 5: Potential for increased R&D spending among U.S. large-cap companies could drive growth for LRND. As companies invest more in research and development, the potential for innovation and technological breakthroughs increases, which could benefit the companies held within LRND's portfolio. This growth opportunity is ongoing and depends on the overall economic environment and the strategic decisions of U.S. large-cap companies.
Opportunities
- Increased investor interest in innovation.
- Expansion of the underlying index.
- Strategic partnerships with financial advisors.
- Development of new marketing campaigns.
Threats
- Uncertainty of R&D outcomes.
- Competition from other ETFs.
- Economic downturn impacting R&D spending.
- Changes in the regulatory environment.
Competitive Advantages
- Focus on R&D leaders provides a unique investment strategy.
- Replication of the NYLI U.S. Large Cap R&D Leaders Index offers a transparent and rules-based approach.
- Cost-effective way to access a portfolio of R&D-focused large-cap companies.
About LRND
NYLI U.S. Large Cap R&D Leaders ETF (LRND) is designed to mirror the investment results of the NYLI U.S. Large Cap R&D Leaders Index. This index is constructed to identify and include U.S. large-cap companies that exhibit a commitment to and effectiveness in research and development (R&D) investment. The ETF provides a targeted approach for investors seeking exposure to innovative companies within the large-cap equity market. By focusing on companies that prioritize R&D, the fund aims to capture potential growth driven by innovation and technological advancement. The ETF's investment strategy involves holding a portfolio of stocks that meet the index's criteria for R&D leadership. The fund operates with the objective of replicating, before fees and expenses, the price and yield performance of its underlying index. This approach allows investors to gain exposure to a specific segment of the market without directly selecting individual stocks. The ETF's focus on R&D leaders distinguishes it from broader market ETFs, offering a more concentrated exposure to companies believed to be at the forefront of innovation. The fund's performance is directly tied to the performance of the NYLI U.S. Large Cap R&D Leaders Index, making it crucial for investors to understand the index's methodology and composition. The ETF is managed with the goal of providing a cost-effective and transparent way to access the returns of R&D-focused large-cap companies.
What They Do
- Tracks the performance of the NYLI U.S. Large Cap R&D Leaders Index.
- Invests in U.S. large-cap equity securities.
- Focuses on companies that demonstrate consistent and effective use of R&D investment.
- Provides investors with exposure to innovation-driven growth.
- Offers a targeted approach to investing in R&D leaders.
- Replicates the price and yield performance of its underlying index before fees and expenses.
Business Model
- Generates revenue through management fees charged to investors.
- Aims to provide investment results that track the performance of the NYLI U.S. Large Cap R&D Leaders Index.
- Offers a cost-effective way for investors to access a portfolio of R&D-focused large-cap companies.
Industry Context
NYLI U.S. Large Cap R&D Leaders ETF operates within the asset management industry, specifically focusing on ETFs. The market for ETFs has seen substantial growth, driven by their diversification benefits and cost-effectiveness. LRND distinguishes itself by targeting companies with significant R&D investments, aligning with the trend of innovation-focused investing. The competitive landscape includes other ETFs with different investment strategies, such as broad market ETFs and sector-specific ETFs. LRND's success depends on the performance of its underlying index and its ability to attract investors seeking exposure to R&D-driven companies.
Key Customers
- Individual investors seeking exposure to innovation-driven growth.
- Institutional investors looking for targeted exposure to R&D leaders.
- Financial advisors seeking to diversify client portfolios with innovation-focused investments.
Financials
Chart & Info
NYLI U.S. Large Cap R&D Leaders ETF (LRND) stock price: Price data unavailable
Latest News
-
Google's Gemma 4 Brings AI Superpowers To Your Device
benzinga · Apr 2, 2026
-
TurboQuant Panic: Why Market Is Wrong About Google's Newest AI Breakthrough
benzinga · Mar 27, 2026
-
Google Accelerates Quantum Timeline: New Dual-Track Strategy Aims For 2030 Commercial Breakthrough
benzinga · Mar 25, 2026
-
Is NYLI U.S. Large Cap R&D Leaders ETF (LRND) a Strong ETF Right Now?
zacks.com · Mar 25, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LRND.
Price Targets
Wall Street price target analysis for LRND.
MoonshotScore
What does this score mean?
The MoonshotScore rates LRND's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Google's Gemma 4 Brings AI Superpowers To Your Device
TurboQuant Panic: Why Market Is Wrong About Google's Newest AI Breakthrough
Google Accelerates Quantum Timeline: New Dual-Track Strategy Aims For 2030 Commercial Breakthrough
Is NYLI U.S. Large Cap R&D Leaders ETF (LRND) a Strong ETF Right Now?
Latest NYLI U.S. Large Cap R&D Leaders ETF Analysis
Common Questions About LRND
What does NYLI U.S. Large Cap R&D Leaders ETF do?
NYLI U.S. Large Cap R&D Leaders ETF (LRND) is an exchange-traded fund designed to track the performance of the NYLI U.S. Large Cap R&D Leaders Index. The fund invests primarily in U.S. large-cap equity securities of companies that demonstrate consistent and effective use of research and development (R&D) investment. By focusing on companies that prioritize R&D, the ETF aims to provide investors with exposure to innovation-driven growth within the large-cap equity market. The fund's investment strategy involves holding a portfolio of stocks that meet the index's criteria for R&D leadership, offering a targeted approach to investing in innovation.
What do analysts say about LRND stock?
AI analysis is currently pending for LRND, so there is no current analyst consensus available. However, key valuation metrics to consider include the fund's expense ratio, tracking error, and the performance of its underlying index. Growth considerations include the potential for innovation-driven growth among the companies held within the portfolio. Investors should monitor the fund's performance relative to its benchmark and assess the long-term prospects of the R&D-focused companies it holds. The fund's beta of 1.09 indicates its volatility relative to the market.
What are the main risks for LRND?
The main risks for NYLI U.S. Large Cap R&D Leaders ETF (LRND) include the uncertainty of R&D outcomes, competition from other ETFs, and the potential for an economic downturn impacting R&D spending. The success of the fund depends on the ability of the companies it holds to generate returns from their R&D investments, which is inherently uncertain. Additionally, LRND faces competition from other ETFs offering exposure to similar investment themes or broader market indices. An economic downturn could also negatively impact R&D spending, potentially affecting the performance of the companies held within the fund.
What are the key factors to evaluate for LRND?
NYLI U.S. Large Cap R&D Leaders ETF (LRND) currently holds an AI score of 44/100, indicating low score. Key strength: Focus on R&D leaders.. Primary risk to monitor: Potential: Uncertainty of R&D outcomes.. This is not financial advice.
How frequently does LRND data refresh on this page?
LRND prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven LRND's recent stock price performance?
Recent price movement in NYLI U.S. Large Cap R&D Leaders ETF (LRND) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on R&D leaders.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider LRND overvalued or undervalued right now?
Determining whether NYLI U.S. Large Cap R&D Leaders ETF (LRND) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying LRND?
Before investing in NYLI U.S. Large Cap R&D Leaders ETF (LRND), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis is pending, limiting the depth of available insights.
- Financial data is limited to market cap and beta.